Examples of genetic screening tests: a complete guide
Genetic screening tests analyse your genes, chromosomes, or genomic regions to assess health risks or identify inherited conditions. The six major categories of genetic tests cover diagnostic, predictive, carrier, prenatal, newborn screening, and pharmacogenetic purposes. Each type serves a distinct clinical goal, which means the right test depends entirely on what question you are trying to answer. Whether you are planning a family, managing a family history of illness, or simply being proactive, understanding these examples of genetic screening tests helps you make genuinely informed decisions.
1. What are diagnostic genetic tests?
Diagnostic genetic tests confirm or rule out a specific genetic condition in someone who already has symptoms or a strong family history. They are not about predicting future risk. They answer the question: “Do I have this condition right now?”
Common examples include:
- Cystic fibrosis confirmation using targeted gene analysis of the CFTR gene
- Huntington’s disease testing to confirm a clinical suspicion based on neurological symptoms
- Chromosomal analysis (karyotyping) to identify structural abnormalities linked to developmental delays
- Gene panel testing for inherited cardiac conditions such as hypertrophic cardiomyopathy
The technology ranges from single-gene analysis to broader gene panels, depending on how many conditions need ruling out. A gene panel tests multiple genes at once, which is useful when several conditions share similar symptoms.
Different testing technologies carry trade-offs in coverage, accuracy, and result complexity. Broader tests find more variants but also produce more results of uncertain significance, which is why clinical interpretation matters enormously.
Pro Tip: Always request a follow-up appointment with a genetic counsellor after receiving diagnostic results. A positive finding is the start of a conversation, not the end of one.
2. How does predictive genetic testing estimate future health risks?
Predictive testing detects inherited mutations before any symptoms appear. It is used when you have a family history of a late-onset condition and want to understand your personal risk level.
The most well-known example is BRCA1 and BRCA2 testing. Carrying a BRCA1 mutation confers a 65% risk of developing breast cancer by age 70. That figure is striking. It does not mean cancer is certain, but it does mean surveillance and preventative options become genuinely worth discussing with a specialist.
Other common predictive testing examples include:
- Lynch syndrome testing for hereditary colorectal cancer risk
- APOE gene testing for Alzheimer’s disease susceptibility
- Familial hypercholesterolaemia screening for inherited high cholesterol
Genetic tests provide probabilities, not certainties. A positive predictive result means your risk is elevated compared to the general population. It does not guarantee you will develop the condition, and a negative result does not mean zero risk. Understanding this distinction is what separates useful genetic information from unnecessary anxiety.
Predictive testing is most valuable when the result changes what you do next. If knowing your risk leads to earlier screening, lifestyle changes, or preventative treatment, the test has done its job.
3. What is carrier genetic testing and why does it matter for family planning?
Carrier testing identifies whether you carry one copy of a gene mutation that could be passed to your children. Carriers typically have no symptoms themselves. The risk arises when both partners carry a mutation for the same recessive condition.
Carrier screening covers multiple conditions, with cystic fibrosis and sickle cell disease among the most commonly tested. If both you and your partner carry a cystic fibrosis mutation, each pregnancy carries a one-in-four chance of the child being affected.
Expanded carrier panels now test for dozens or even hundreds of conditions simultaneously. This is a significant shift from the older approach of testing for single conditions based on ethnicity. The expanded approach catches more at-risk couples regardless of background.
Here is how the carrier testing process typically works:
- A blood or saliva sample is collected from one or both partners.
- The laboratory analyses specific gene variants associated with recessive conditions.
- Results are returned, usually within two to four weeks.
- A genetic counsellor reviews the results and explains what they mean for your reproductive options.
- If both partners are carriers, further options such as preimplantation genetic testing or prenatal diagnosis are discussed.
For couples planning a family, fertility testing and carrier screening work hand in hand. Knowing your carrier status before conception gives you the most options. If you wait until pregnancy, the timeline for decisions becomes much tighter.
Pro Tip: Both partners should ideally be tested at the same time. Testing only one partner first can create delays and unnecessary worry if that result comes back positive.
4. Which prenatal genetic screening tests assess fetal risk during pregnancy?
Prenatal genetic screening tests assess the likelihood that a developing baby has a chromosomal abnormality or inherited condition. The key word is “likelihood.” Screening tests estimate risk. They do not confirm a diagnosis.
Cell-free fetal DNA testing, also called non-invasive prenatal testing (NIPT) or cffDNA testing, is currently the most sensitive screening method for Down syndrome. It analyses fragments of fetal DNA found in the mother’s blood from around ten weeks of pregnancy. It also screens for trisomy 18, trisomy 13, and sex chromosome conditions.
The distinction between screening and diagnostic prenatal tests is clinically critical:
| Feature | Prenatal screening (e.g. NIPT) | Prenatal diagnostic (e.g. amniocentesis, CVS) |
|---|---|---|
| Method | Maternal blood test or ultrasound | Invasive sample from placenta or amniotic fluid |
| Result type | Risk estimate (probability) | Confirmatory diagnosis |
| Miscarriage risk | None | Small but present |
| Timing | From 10 weeks (NIPT) | 10–13 weeks (CVS), 15–20 weeks (amniocentesis) |
| Use case | First-line screening for all pregnancies | Follow-up after a high-risk screening result |
Screening estimates risk non-invasively, while diagnostic tests carry a small miscarriage risk but provide a definitive answer. A high-risk NIPT result does not mean your baby has a chromosomal condition. It means diagnostic testing is the appropriate next step.
Ethical considerations matter here too. Some couples choose not to screen at all. Others want every piece of information available. Neither approach is wrong. What matters is that you make the choice that fits your values, with full information.
5. What newborn genetic screening tests are routinely performed?
Newborn screening is one of the most successful public health programmes in modern medicine. It tests babies in the first days of life for conditions that are treatable but show no obvious symptoms at birth.
Newborn screening panels commonly include:
| Condition | Why it is screened | Treatment if detected |
|---|---|---|
| Phenylketonuria (PKU) | Causes brain damage if untreated | Dietary restriction of phenylalanine |
| Sickle cell disease | Causes severe anaemia and organ damage | Preventative antibiotics, specialist care |
| Cystic fibrosis | Causes lung and digestive damage | Early physiotherapy and medication |
| Congenital hypothyroidism | Causes developmental delay | Thyroid hormone replacement |
| SCID | Severe immune deficiency, fatal without treatment | Bone marrow transplant |
| Spinal muscular atrophy (SMA) | Progressive muscle weakness | Gene therapy, most effective when started early |
Newborn screening uses biochemical and molecular tests to detect these conditions before symptoms appear. Early detection is the entire point. For conditions like SMA, starting treatment in the first weeks of life produces dramatically better outcomes than waiting for symptoms.
Pro Tip: If your baby’s newborn screening result comes back positive, do not panic. A positive screen is not a confirmed diagnosis. Follow-up diagnostic testing is always the next step.
6. How does pharmacogenetic testing personalise medication choices?
Pharmacogenetic testing examines how your genetic variants affect the way your body processes medications. The goal is to match the right drug and dose to your biology, rather than relying on trial and error.
Over 26 clinical guidelines from the Clinical Pharmacogenetics Implementation Consortium (CPIC) now cover 29 genes and 100 drugs. That is a significant body of evidence supporting clinical use.
Clinically relevant examples include:
- CYP2C19 and clopidogrel (a blood thinner): poor metabolisers of this gene variant may not activate the drug effectively, increasing clot risk
- CYP2D6 and codeine: certain variants cause rapid metabolism, leading to dangerously high morphine levels
- TPMT and azathioprine: low enzyme activity variants increase the risk of severe bone marrow toxicity
- HLA-B*5701 and abacavir: carriers of this variant have a high risk of severe hypersensitivity reaction to this HIV medication
Pharmacogenetic testing is most useful before starting a new medication, particularly for psychiatric drugs, anticoagulants, and chemotherapy agents. The limitation is that not all drugs have established guidelines yet, and implementation across NHS settings remains inconsistent. If you are considering genetic counselling alongside pharmacogenetic results, a specialist can help interpret what the findings mean for your specific treatment plan.
Key takeaways
Genetic screening tests fall into six distinct categories, each designed to answer a different clinical question, and choosing the right type is the single most important step in getting useful results.
| Point | Details |
|---|---|
| Six test categories exist | Diagnostic, predictive, carrier, prenatal, newborn, and pharmacogenetic tests each serve a different purpose. |
| Screening results are probabilities | A positive screening result estimates risk. It requires follow-up diagnostic testing to confirm any diagnosis. |
| Carrier testing is a couple’s decision | Both partners should be tested simultaneously to assess reproductive risk accurately and save time. |
| NIPT is the most sensitive prenatal screen | Cell-free fetal DNA testing is the leading non-invasive method for detecting chromosomal conditions from 10 weeks. |
| Pharmacogenetics is clinically supported | CPIC guidelines cover 29 genes and 100 drugs, making pharmacogenetic testing a practical tool in medication planning. |
What I have learned from years of watching people navigate genetic testing
People tend to approach genetic testing in one of two ways. They either want every possible answer before making any decision, or they avoid testing entirely because they are afraid of what they might find out. Both reactions are understandable. Neither is particularly useful on its own.
The most important thing I have seen people miss is this: a genetic test result is information, not a verdict. A BRCA1 positive result does not mean you will get cancer. A carrier result does not mean your children will be affected. What these results do is give you a clearer picture so you can make better choices, whether that is more frequent screening, earlier conversations with a specialist, or simply peace of mind.
The other thing worth saying plainly is that direct-to-consumer genetic tests sold online are not the same as clinical genetic tests. They can be a useful starting point, but they test a limited range of variants and rarely come with the interpretation support you actually need. For anything that will influence a medical or reproductive decision, a clinically validated test with proper counselling is the right route.
Understanding your genetic risk is not about living in fear of what might happen. It is about having enough information to act sensibly. That is a very different thing.
— Jack
Fertility and health screening you can do at home
Genetic screening gives you the bigger picture of inherited risk. But fertility health is something you can start checking right now, without a clinic appointment or a long wait.
Rapidtest offers at-home fertility testing kits for both men and women, with results in 15 minutes. No queues, no awkward conversations, no waiting rooms. Whether you are just starting to think about having children or actively trying to conceive, knowing your fertility baseline is a genuinely useful first step. Rapidtest kits are accurate, affordable, and designed to fit around your life. You can also explore the Couples Fertility Bundle if you and your partner want to test together.
FAQ
What are the main examples of genetic screening tests?
The six main types are diagnostic, predictive, carrier, prenatal, newborn screening, and pharmacogenetic tests. Each addresses a different clinical question, from confirming an existing condition to assessing inherited risk before symptoms appear.
Is a positive genetic screening result a confirmed diagnosis?
No. Genetic screening results provide risk probabilities, not confirmed diagnoses. A positive screen always requires follow-up diagnostic testing to confirm or rule out a condition.
When should couples consider carrier genetic testing?
Carrier testing is most useful before conception, as it gives couples the widest range of reproductive options. It is recommended for anyone with a family history of a recessive genetic condition or as part of routine preconception planning.
What does NIPT test for during pregnancy?
Non-invasive prenatal testing (NIPT) screens for chromosomal conditions including Down syndrome (trisomy 21), trisomy 18, trisomy 13, and sex chromosome abnormalities using a sample of the mother’s blood from around 10 weeks of pregnancy.
How is pharmacogenetic testing different from other genetic tests?
Pharmacogenetic testing focuses specifically on how your genes affect your response to medications. Rather than assessing disease risk, it helps clinicians choose the right drug and dose for your individual biology, guided by CPIC clinical guidelines.